Results 41 to 50 of about 1,854 (76)

Pitiriasis Rubra Pilaris clásica juvenil post infecciosa, reporte de tres casos.

open access: closed, 2021
Pamela Iglesias Boisier   +2 more
openalex   +2 more sources

Pitiriasis rubra pilaris exuberant type III in children

open access: closedJournal of the American Academy of Dermatology, 2011
openaire   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Biologics for Treatment of Pityriasis Rubra Pilaris: A Literature Review

Journal of Cutaneous Medicine and Surgery
Objective: To describe the published efficacy and adverse event rates associated with existing biologics for the treatment of pityriasis rubra pilaris (PRP).
R. Chandy   +3 more
semanticscholar   +1 more source

Guselkumab for Pityriasis Rubra Pilaris and Dysregulation of IL-23/IL-17 and NFkB Signaling: A Nonrandomized Trial.

JAMA dermatology
Importance There is no US Food and Drug Administration-approved treatment for pityriasis rubra pilaris (PRP), and it is common for patients to fail to experience improvement with several systemic options.
R. Velasco   +7 more
semanticscholar   +1 more source

A Review on Pityriasis Rubra Pilaris

American Journal of Clinical Dermatology, 2018
Dingyuan Wang, Hazel H Oon
exaly  

Pitiriasis rubra pilaris. Reporte de un caso

open access: closed, 2004
Patricia Ramírez Bárcena   +2 more
openalex  

Home - About - Disclaimer - Privacy